Stock Comparison

GYRE vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricGYREGyre Therapeutics, Inc.AAPLApple Inc.
Market Cap$741.77M$3.8T
Current Price$7.70$258.21
P/E Ratio15434.61
Revenue Growth 1Y-6.8%6.4%
Net Margin11.4%26.9%
ROE21.5%171.4%
ROIC35.1%70.6%
Debt/Equity0.021.34
FCF Yield2.6%
Dividend Yield0.4%
Loading chart...

GYRE vs AAPL: Key Questions Answered

Which is the cheapest stock: GYRE or AAPL?

Based on P/E ratio, Apple Inc. (AAPL) is the cheapest at 34.6x earnings. Gyre Therapeutics, Inc. (GYRE) is the most expensive at 154.0x. A lower P/E can indicate better value, but always consider growth rates too.

Which stock is growing the fastest: GYRE or AAPL?

Apple Inc. (AAPL) is growing the fastest with 6.4% revenue growth. Gyre Therapeutics, Inc. has the slowest growth at -6.8%. Higher growth often justifies higher valuations.

Which has the best profit margins: GYRE or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. Gyre Therapeutics, Inc. has the lowest at 11.4%. Higher margins indicate pricing power and efficiency.

Which is the largest company: GYRE or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.80T. Gyre Therapeutics, Inc. is the smallest at $0.7B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: GYRE or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. Gyre Therapeutics, Inc. has the lowest at 21.5%. Higher ROE indicates efficient use of capital.